Waleed H. Hassanein - 23 Feb 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
23 Feb 2023
Net transactions value
-$2,786,085
Form type
4
Filing time
27 Feb 2023, 19:00:52 UTC
Previous filing
22 Feb 2023
Next filing
02 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Sale $435,922 -6,200 -1.5% $70.31 420,244 23 Feb 2023 Direct F1, F2
transaction TMDX Common Stock Sale $342,835 -4,807 -1.1% $71.32 415,437 23 Feb 2023 Direct F1, F3
transaction TMDX Common Stock Sale $262,659 -3,577 -0.86% $73.43 411,860 23 Feb 2023 Direct F1, F4
transaction TMDX Common Stock Sale $241,668 -3,243 -0.79% $74.52 408,617 23 Feb 2023 Direct F1, F5
transaction TMDX Common Stock Sale $1,503,000 -20,000 -4.9% $75.15 388,617 23 Feb 2023 Direct F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.85, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $71.00 to $71.63, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $73.10 to $73.93, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $74.00 to $74.90, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $75.00 to $75.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F7 Includes 37,332 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.